Trial
NCT03721965
Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Incyte Corporation
Collaborators
—
Condition
Acute Graft-versus-host Disease
Intervention
Itacitinib
Why stopped
The study was terminated due to insufficient efficacy in a separate phase III study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-04